Genomic Alteration in Metastatic Breast Cancer and Its Treatment

Epigenetic mechanisms in breast cancer therapy and resistance

Molecular profiling for precision cancer therapies

PDF] Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

Comparative analysis of protein-protein interaction networks in metastatic breast cancer

Comparative analysis of protein-protein interaction networks in metastatic breast cancer

Precision Medicine for Metastatic Breast Cancer

Brazilian Journal Of Oncology - Implementing somatic mutation testing in clinical setting: recommendations from a panel of experts

MP-guided treatment. (A) Targetable genomic alterations (n = 81

Metastatic Breast Cancer Explained: Symptoms, Diagnosis & More

Clinical relevance of the insights provided by NGS in breast

HTRA1 and HTRA2 expression differentially modulate the clinical prognosis of cancer: a multi-omics analysis using bioinformatics approaches

Brazilian Journal Of Oncology - Implementing somatic mutation testing in clinical setting: recommendations from a panel of experts